Asuragen’s Xpansion Interpreter® Test Study of 1,040 Transmissions of Fragile X Alleles

News   Sep 20, 2014

 
Asuragen’s Xpansion Interpreter® Test Study of 1,040 Transmissions of Fragile X Alleles
 
 
 

RELATED ARTICLES

Biomarkers Could Produce Preeclampsia Diagnostic Test

News

Small non-coding RNA analysis may revolutionize how doctors assess preeclampsia risk.

READ MORE

CRISPR Rescues Fragile X Syndrome Neurons

News

The gene editing technology CRISPR has been used to restore normal activity in neurons affected by Fragile X Syndrome.

READ MORE

Sequencing Shows How Evolution Can Undermine Bioprocess Commercialization

News

Rapid evolution can suppress the effect of pro-production genes in biochemical processes.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE